Physician

Richard Edwin Jones, MD

According to 2025 Medicare claims, Richard Jones, MD (NPI: 1174507800) practices rheumatology in the Tuscaloosa, AL market, with the plurality of this provider's patient population coming from Tuscaloosa, AL. This provider's primary affiliated billing organization is WV MEDICAL SERVICES PC (NPI: 1497739346; TIN: 631243197) and primary practice location at 35473-5163.

Jones' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 882 traditional Medicare patients, billed 298,925 HCPCS/CPT codes, and received $4,239,696 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 6,239 prescription claims across 947 beneficiaries totaling $9,002,169 in drug costs, led by Acthar (Corticotropin). DME data shows 27 claims. Open Payments data shows 182 records totaling $82,588. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $3,466,994 and ending at $9,002,169. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $11,562 to $709.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,014	420,920	$6,390,696
2016	1,941	340,472	$4,934,811
2017	1,692	347,131	$5,794,158
2018	1,600	417,735	$6,582,112
2019	1,685	414,074	$6,607,644
2020	1,581	401,775	$6,230,224
2021	1,465	366,178	$5,224,242
2022	1,354	416,924	$5,107,752
2023	1,034	360,720	$4,515,302
2024	882	298,925	$4,239,696

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	1,087	9,336	$3,466,994
2016	986	7,398	$7,228,177
2017	779	4,978	$6,941,070
2018	783	5,235	$7,714,151
2019	818	5,017	$11,230,062
2020	690	4,365	$10,656,322
2021	659	3,363	$6,929,845
2022	740	4,077	$3,830,952
2023	936	5,677	$4,945,093
2024	947	6,239	$9,002,169

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	61	103	$33,363
2016	43	56	$17,127
2017	24	24	$3,430
2018	15	15	$2,488
2019	29	29	$3,034
2020	20	32	$4,760
2021	13	61	$1,521
2022	14	25	$23,945
2023	N/R	12	$27,398
2024	N/R	27	$34,535

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	668	1,272	$84
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	638	1,076	$12
80053	Blood test, comprehensive group of blood chemicals	628	1,299	$10
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	483	1,091	$7
86140	Measurement c-reactive protein for detection of infection or inflammation	477	1,085	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Acthar	Corticotropin	44	1,082	$2,797,003
Humira(Cf) Pen	Adalimumab	114	3,360	$971,495
Enbrel Sureclick	Etanercept	117	3,276	$863,315
Cimzia (2 Pack)	Certolizumab Pegol	86	2,408	$492,908
Rinvoq	Upadacitinib	65	1,950	$411,728

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1561	Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg	N	N/R	13	$29,920
Q2052	Services, supplies and accessories used in the home for the administration of intravenous immune globulin (ivig)	N	N/R	14	$4,615

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	179	$4,223	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	3	$78,364	Novartis Pharmaceuticals Corporation
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Richard Edwin Jones, MD?

Tedicare shows public-source Medicare data for Richard Edwin Jones, MD (NPI 1174507800), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Richard Edwin Jones, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Richard Edwin Jones, MD?

Richard Edwin Jones, MD is linked to WV MEDICAL SERVICES PC (billing NPI 1497739346) in the available physician profile data.

Does Richard Edwin Jones, MD have Open Payments data?

Richard Edwin Jones, MD has 182 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.